胸腹主动脉瘤腔内修复术后脊髓缺血发生率的系统综述与荟萃分析
该系统综述与荟萃分析纳入27项研究共2333例胸腹主动脉瘤腔内修复(TAAA-ER)患者,评估脊髓缺血(SCI)发生率。汇总SCI发生率为11%(95%CI 8%-15%;I²=79%),分期修复较非分期修复SCI发生率更低(9% vs 18%,P=.02)。永久性SCI汇总率为6%,30天死亡率为7%,分期间死亡率为1.6%。
要点
- TAAA-ER后SCI汇总发生率为11%(95%CI 8%-15%;I²=79%),其中约一半为永久性。
- 分期修复SCI发生率低于非分期修复(9% vs 18%,P=.02),与分期时机和方法无关。
- 症状性CSFD与预防性CSFD的SCI汇总发生率相似(10% vs 10%,P=.99)。
核心结论
- TAAA-ER后SCI发生于11%的患者,其中一半为永久性。
- 分期修复可独立于时机和方法降低SCI发生率。
- 分期TAAA-ER总体死亡率为7%,其中五分之一(1.6%)发生在分期之间。
研究设计与样本
- 系统综述与荟萃分析,纳入报告TAAA-ER后SCI发生率的队列研究和病例系列(>20例患者)。
- 共纳入27项研究、2333例患者。
- 主要结局指标为SCI评估,调节因素包括分期与非分期、脑脊液引流(CSFD)使用及TAAA范围。
主要发现
- SCI汇总估计值为11%(95%CI 8%-15%;I²=79%)。
- 范围I、II、III、V型TAAA的SCI汇总率为13%(95%CI 10%-17%;I²=69%)。
- 范围IV型TAAA的SCI汇总率为6%(95%CI 3%-10%;I²=62%)。
- 分期TAAA-ER较非分期TAAA-ER的SCI汇总率更低(9% vs 18%,P=.02)。
- 分期在>1个月完成的研究有9项,≤1个月完成的研究有2项,SCI发生率相似(7% vs 11%,P=.26)。
关键数值与推荐
- 20项研究采用分期TAAA-ER,8项采用非分期(1项研究同时包含两种)。
- 分期方法(胸主动脉内移植物或临时主动脉囊灌注)不影响SCI发生率。
- 症状性CSFD与预防性CSFD的SCI汇总率相似(10% vs 10%,P=.99)。
- 永久性SCI汇总率为6%(范围I、II、III、V型TAAA为6%;范围IV型TAAA为3%)。
- 30天死亡率汇总率为7%,分期与非分期相似(6% vs 9%)。
临床怎么用
- 分期修复TAAA-ER较非分期修复与更低的SCI发生率相关(9% vs 18%,P=.02)。
- 分期时机(>1个月 vs ≤1个月)及分期方法对SCI发生率无显著影响。
- 症状性CSFD与预防性CSFD的SCI发生率相似(10% vs 10%,P=.99)。
- 分期间死亡率汇总为1.6%,见于9项研究报告。
局限性
- SCI汇总估计值异质性I²=79%。
- 范围I、II、III、V型TAAA的SCI汇总率异质性I²=69%。
- 范围IV型TAAA的SCI汇总率异质性I²=62%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The rate of endovascular repair of thoracoabdominal aortic aneurysms (TAAA-ER) has increased considerably in recent years. Although the mortality and morbidity rates have improved, the incidence of spinal cord ischemia (SCI) has not declined significantly. The aim of the present systematic review and meta-analysis was to examine the SCI rates with respect to the efficacy of the different approaches. METHODS: Cohort studies and case series (>20 patients) reporting SCI rates after TAAA-ER were eligible for inclusion. The primary outcome measure was the evaluation of SCI. The moderators considered were primarily the staged vs nonstaged approach, the use of cerebrospinal fluid drainage (CSFD), and TAAA extension. The permanent SCI and mortality rates were extracted. RESULTS: A total of 27 studies with 2333 patients were included in the meta-analysis. The pooled estimate for SCI was 11% (95% confidence interval [CI], 8%-15%; I2, 79%). For extent I, II, III, and V TAAA, the pooled SCI rate was 13% (95% CI, 10%-17%; I2, 69%). For extent IV TAAA, the pooled SCI rate was 6% (95% CI, 3%-10%; I2, 62%). A staged TAAA-ER approach was used in 20 studies and a nonstaged approach in 8 (1 study had included both). A lower pooled SCI rate was identified after staged than after nonstaged TAAA-ER (9% vs 18%, respectively; P = .02). Staging was accomplished in >1 month in nine studies and ≤1 month in two studies, leading to similar SCI rates (7% vs 11%, respectively; P = .26). The method of staging (thoracic endoprosthesis or temporary aortic sac perfusion) did not affect the SCI rates. Symptomatic CSFD was associated with a similar pooled rate of SCI compared with prophylactic CSFD (10% vs 10%, respectively; P = .99). The pooled permanent SCI rate was 6% (6% for extent I, II, III, and V TAAA; and 3% for extent IV TAAA). The pooled rate of 30-day mortality was 7%, with a similar incidence for the staged and nonstaged approaches (6% vs 9%, respectively). Interstage mortality was reported in 9 studies, with a pooled estimate rate of 1.6%. CONCLUSIONS: SCI had occurred in 11% of TAAA-ER, and one half of these cases were permanent. A staged approach can reduce SCI rates independently of the timing and method adopted. The overall mortality rate for staged TAAA-ER was 7%, with one fifth of the deaths (1.6%) occurring between stages.
引用
- Pini R, Faggioli G, Paraskevas KI, et al. A systematic review and meta-analysis of the occurrence of spinal cord ischemia after endovascular repair of thoracoabdominal aortic aneurysms. J Vasc Surg. 2021. PMID: 34736999. doi:10.1016/j.jvs.2021.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。